Resmed Inc (RMD) Return on Equity ROE from the first quarter 2026 to first quarter 2026 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Resmed Inc   (NYSE: RMD)

Resmed Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Resmed Inc in the first quarter 2026?
Resmed Inc achieved a return on average equity (ROE) of 25.14 % in its first quarter 2026, this is above RMD's average return on equity of 20.66%.
Resmed Inc s equity during the 12 months ending in the first quarter 2026 are valued at $6 billion

ROE has advanced compared to 23.88% in the fourth quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 10 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2026 from 475 to 515.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
I. Quarter		 (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter
Y / Y Equity Change -2.84 % 10.35 % 17.05 % 20.33 % -
Y / Y Net Income Change 20.05 % 0.98 % 9.23 % 13.92 % 11.94 %
Net Income (TTM) in Millions 1,593 1,523 1,520 1,486 1,438
Return On Equity (TTM) 25.14 % 23.88 % 24.41 % 24.81 % 25.13 %
RMD's Total Ranking # 515 # 475 # 352 # 405 #
Equity (TTM) in Millions 5,948 6,585 6,492 6,321 6,121
Seq. Equity Change -9.68 % 1.44 % 2.71 % 3.26 % 2.57 %
Seq. Net Income Change 9.12 % -3.84 % 1.56 % 12.64 % -8.21 %

Back to RMD Management Effectiveness >> RMD's 5 Years Annual ROE >> Compare RMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 11
Sector # 64
Overall # 515

Return On Equity Statistics
High Average Low
28.61 %
20.66 %
8.21 %
(Sep 30 2020)   (Jun 30 2013)





RMD Annual Return On Equity (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Equity in Millions 6,585 5,968 4,864 4,130 3,361
Y / Y Equity Change 10.35 % 22.69 % 17.78 % 22.89 % 16.46 %
Net Income in Millions 1,523 1,401 1,021 898 779
Y / Y Net Income Change 8.75 % 37.2 % 13.75 % 15.15 % 64.26 %
Return On Equity 23.13 % 23.47 % 20.99 % 21.73 % 23.19 %

Back to RMD Management Effectiveness >> RMD's 5 Years Annual ROE >> Compare RMD ROE to its Competitors




Annual Roe Comment
In 2026 ROE fell to 23.13 %, despite net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RMD's' Return on Equity at Yahoo Finance
RMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RMD's Competitors
Subscribers only: Roe for Resmed Inc 's Suppliers
Subscribers only: Return On Equity for RMD's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Tenet Healthcare Corp  57.13 %
Aurinia Pharmaceuticals Inc   51.92 %
Nurix Therapeutics Inc   49.34 %
Carlisle Companies Incorporated  44.18 %
Bristol myers Squibb Company  43.83 %
Zevra Therapeutics Inc   38.02 %
Dexcom Inc   36.56 %
Rallybio Corporation  36.35 %
Caredx Inc   34.08 %
Chemed Corporation  32.10 %
Illumina Inc   31.45 %
Transmedics Group Inc   28.74 %
Acadia Pharmaceuticals Inc   28.03 %
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %

Date modified: 2026-10-31T10:01:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.